Skip to main content

and
  1. Article

    Correction: Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit

    Antoine Gaillet, Pierre Bay, Edwige Péju, Hafid Ait-Oufella in Intensive Care Medicine (2023)

  2. Article

    Open Access

    French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

    Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be ...

    Matthieu Groh, Julien Rohmer, Nicolas Etienne in Orphanet Journal of Rare Diseases (2023)

  3. No Access

    Article

    Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unit

    Although eosinophil-induced manifestations can be life-threatening, studies focusing on the epidemiology and clinical manifestations of eosinophilia in the intensive care unit (ICU) are lacking.

    Antoine Gaillet, Pierre Bay, Edwige Péju, Hafid Ait-Oufella in Intensive Care Medicine (2023)

  4. Article

    Correction to: Protein‑losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable Immunodeficiency

    Sébastien Sanges, Nicolas Germain, Stéphane Vignes in Journal of Clinical Immunology (2023)

  5. No Access

    Article

    Protein-losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable Immunodeficiency

    As protein-losing enteropathy (PLE) can lead to hypogammaglobulinemia and lymphopenia, and since common variable immunodeficiency (CVID) is associated with digestive complications, we wondered if (1) PLE could...

    Sébastien Sanges, Nicolas Germain, Stéphane Vignes in Journal of Clinical Immunology (2022)

  6. Article

    Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases

    Enagnon Kazali Alid**ou, Julie Demaret, Laurence Bocket, Fanny Vuotto in Infection (2022)

  7. No Access

    Article

    Eosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies

    Eosinophils are often considered as the pathologic landmark of chronic rhinosinusitis with nasal polyps (CRSwNP). Many studies emphasize their pivotal role in mucosal remodeling by their innate action via cyto...

    Thibault Vanderhaegen, Isabelle Gengler in Clinical Reviews in Allergy & Immunology (2022)

  8. Article

    Open Access

    Venous thrombosis and predictors of relapse in eosinophil-related diseases

    Eosinophils have widespread procoagulant effects. Eosinophilic cardiovascular toxicity mostly consists of endomyocardial damage or eosinophilic vasculitis, while reported cases of venous thrombosis (VT) are sc...

    Valériane Réau, Alexandre Vallée, Benjamin Terrier, Aurélie Plessier in Scientific Reports (2021)

  9. No Access

    Article

    A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

    Patients with primary immunodeficiency (PID) are at risk of serious complications. However, data on the incidence and causes of emergency hospital admissions are scarce. The primary objective of the present st...

    Hélène Coignard-Biehler, Nizar Mahlaoui, Benoit Pilmis in Journal of Clinical Immunology (2019)

  10. Article

    Open Access

    Prognostic value of PCT in septic emergency patients

    An accurate assessment of septic patients at risk for poor clinical outcomes is challenging for clinicians in the emergency department (ED).

    Nicolas Peschanski, Camille Chenevier-Gobeaux, Lynda Mzabi in Annals of Intensive Care (2016)

  11. Article

    Open Access

    Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

    The risk of serious bacterial infectious events (SIEs) after an RTX course used in severe and refractory cases of systemic autoimmune diseases (SAID) is well known. Risk factors for SIEs merit investigation. F...

    Marion Heusele, Pierre Clerson, Benoit Guery, Marc Lambert in Clinical Rheumatology (2014)

  12. Article

    Infection by H1N1 flu virus revealing T-cell acute lymphoid leukaemia: about two cases

    Guillaume Lefevre, Jean-Christophe Ianotto, Adrian Tempescul in Annals of Hematology (2011)

  13. No Access

    Article

    Gestion informatisée du contrôle de qualité

    Sophie Bailleul, Guillaume Lefevre in Biotribune Magazine (2006)

  14. No Access

    Article

    Exploration biologique des risques cardio-vasculaires chez le diabétique

    Le diabète est un des principaux facteurs de risques cardio-vasculaires et son exploration biologique permet de dépister, voire de prévenir, par un bon suivi, les conséquences de type athéromateux de cette pat...

    Christine Morin, Michèle Fonfrede, Guillaume Lefevre in BioTribune Magazine (2004)

  15. No Access

    Article

    Marqueurs biologiques de souffrance cardiaque

    Les étiologies cardiovasculaires représentent une source de recrutement importante pour les services des urgences et sont à l’origine d’une prescription croissante d’analyses biologiques. Les maladies cardiova...

    Guillaume Lefèvre in BioTribune Magazine (2004)

  16. No Access

    Article

    Questions — Réponses sur les dosages des troponines

    L’apparition de nouveaux tests de diagnostic cardiologique a profondément modifié l’implication du biologiste dans le diagnostic et le suivi des syndromes coronariens aigus. A côté des progrès fondamentaux sur...

    Guillaume Lefèvre in Bio tribune magazine (2002)